Powder for injections Blitsef is applied to treatment of infections which causative agents are sensitive to a tseftriakson:

• respiratory infection, especially pneumonia and also infections of an ear, throat and nose;
• an infection of abdominal organs (peritonitis, infections of biliary tract and digestive tract);
• an infection of kidneys and urinary tract;
• an infection of genitals, including gonorrhea;
• sepsis;
• an infection of bones, joints, soft tissues, skin and also wound fevers;
• an infection at patients with the weakened immunity;
• meningitis;
• disseminate borreliosis of Lyme (early and late stages of a disease);

Structure

Active ingredient: tseftriakson;

1 bottle supports a tseftriakson of sodium is equivalent to a tseftriakson - 1000 mg;

Contraindication

Hypersensitivity to cephalosporins. In the presence at the patient of hypersensitivity to penicillin it is necessary to consider a possibility of cross allergic reaction to Blitsef.

Hyperbilirubinemia at newborn and premature. In the researches in vitro it was shown what tseftriakson can force out bilirubin from communication with blood serum albumine that can result in risk of developing the encephalopathy caused by bilirubin.

cannot be applied Blitsef from kaltsiysoderzhashchy solutions At all (Ringera solution, etc.)! It is not necessary to appoint Kaltsiysoderzhashchy solutions within 48 hours after the last introduction of a tseftriakson.

Route of administration

Adults and children are aged more senior than 12 years usually appoint 1-2 g of medicine of 1 times a day (each 24 hours). In heavy infections or infections which causative agents have only moderate sensitivity to a tseftriakson it is possible to increase a daily dose to 4 g

Feature of application

Pregnant

during pregnancy, especially in the I trimester, tseftriakson it is possible to apply, only if the advantage exceeds risk.

Children

to use Drug to children according to a dosage.

Drivers

With care.

Overdose

in case of overdose the hemodialysis or peritoneal dialysis will not reduce concentration of medicine.

symptomatic treatment.

Specific antidote does not exist.

Side effects

• from the system of blood and lymphatic system: widespread: eosinophilia, leukopenia, granulocytopenia, hemolytic anemia, thrombocytopenia, increase in a prothrombin time.
• from a digestive tract: often: diarrhea, nausea, vomiting, stomatitis, glossitis.
• from digestive system: very often: precipitated calcium superphosphates of calcic salt of a tseftriakson in a gall bladder with the corresponding symptomatology at children, the return a cholelithiasis at children.
• from skin and hypodermic cellulose: often: rash, allergic dermatitis, itch, small tortoiseshell, hypostases, dieback.
• from an urinary system: seldom: oliguria, hamaturia, glucosuria.

Interaction

cannot be applied Blitsef from kaltsiysoderzhashchy solutions At all (Ringera solution, etc.)!

should not appoint Kaltsiysoderzhashchy solutions within 48 hours after the last introduction of a tseftriakson.

At newborn and premature children described cases of emergence of precipitated calcium superphosphates in the lungs and kidneys which entailed a lethal outcome at simultaneous introduction of a tseftriakson and medicines of calcium.

to Store

in original packing at a temperature not above 25 °C.

to Store

out of children's reach.

Prepared solution to store

no more than 6 hours at the room temperature and no more than 24 hours at a temperature of 2 ° - 8 °C.

Expiration date - 3 years.